Stay updated on Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Major update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-06T04:24:25.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Removed several Neoplasms and Carcinoma-related terms and added a new version identifier v3.1.0. The page now presents fewer taxonomic categories and indicates the updated version.
    Difference
    0.7%
    Check dated 2025-09-28T23:42:09.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.0.2 is now shown, replacing v3.0.1; the Back to Top control was removed.
    Difference
    0.2%
    Check dated 2025-09-14T09:55:06.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T07:52:07.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has added significant medical terminology related to ovarian and female urogenital diseases, as well as the facility name and location, while removing various related resources and terms.
    Difference
    5%
    Check dated 2025-08-31T00:58:21.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T20:09:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.